I recently found an interesting on-line article by Eric Staeva-Vieira, PhD entitled “The Three Pillars of Biotechnology Equity Research,” and thought it would be of interest to PRN members and readers.

(more…)

Dr. Shelley Chu joined Frazier Healthcare in 2005 as a Vice President and became a Principal in 2007.  Dr. Chu is a member of Frazier Healthcare’s biopharma investment team and has played significant roles in the firm’s investments in Intradigm Corporation, Cadence Pharmaceuticals, Cerexa, and Arete Therapeutics among others.  (more…)

Dr. Yamada joined Frazier Healthcare Ventures in 2006 as a Senior Advisor to the biopharma team. (more…)

August M. Watanabe, MD, joined Frazier Healthcare Ventures in 2005 as Senior Advisor to the Biopharma team.   (more…)

MedImmune Ventures, Inc. is a wholly owned venture capital subsidiary of MedImmune, Inc. It was created in 2002 to leverage the company’s expertise in discovering, developing and commercializing biotechnology products, as well as its financial resources, to transform new ideas in biotechnology into successful products and companies. (more…)

Joe Amprey is a member of the Metastatix Board of Directors and is also a Principal at MedImmune Ventures. (more…)

Drew Senyei, MD, is a managing director at Enterprise Partners  where he leads the life science practice. Drew focuses on investments in pharmaceuticals, biopharmaceuticals, diagnostics, medical devices and consumer healthcare. (more…)

Mike Diem is a Principal at SR One and a member of the Metastatix Board of Directors.
He joined SR One in 2005 and is a Kauffman Fellow. He is currently a board director at CalciMedica and a board observer at Trinity Biosystems and Protez Pharmaceuticals.

(more…)

Dr. Whitcomb joined Frazier Healthcare Ventures in mid-2007 as a Senior Advisor to the Biopharma investment team. Prior to Frazier Healthcare, Dr. Whitcomb was a Founder and Senior Clinical Research Fellow at QuatRx Pharmaceuticals and currently serves as a consultant to multiple biotechnology companies. (more…)

The AscendHealth Corporation is a newly established behavioral healthcare company whose President and CEO, Richard Kresch, M. D., has maintained a successful 30 year leadership and entrepreneurial record in both the not-for-profit and proprietary sectors. (more…)